Ezmekly
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ezmekly, covering 2026-04-21 to 2026-08-13. Get the full timeline:
Most recent: EMA Authorised: Ezmekly (mirdametinib) — Merck Europe B.V.
2 regulatory and trial events tracked for Ezmekly, covering 2026-04-21 to 2026-08-13. Get the full timeline:
Most recent: EMA Authorised: Ezmekly (mirdametinib) — Merck Europe B.V.